Aortic Valve Replacement With Trifecta(TM)
- Conditions
- Aortic Valve StenosisRegurgitation, Aortic ValveAortic Valve IncompetenceAortic Valve Insufficiency
- Registration Number
- NCT00475267
- Lead Sponsor
- Abbott Medical Devices
- Brief Summary
The purpose of this study is to confirm the clinical safety and effectiveness of the Trifecta valve.
- Detailed Description
The clinical investigation is a multi-center, multi-country, prospective, non-randomized, observational study designed to evaluate the safety and effectiveness of the Trifecta valve.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 203
- Requires aortic valve replacement (heart surgery such as bypass is allowed at the same time).
- Legal age.
- Signed informed consent prior to surgery.
- Willing to complete all follow-up requirements.
- Pregnant or nursing women.
- Have already had a valve replaced other than the aortic valve.
- Needs another valve replaced.
- Cannot return for required follow-up visits.
- Have active endocarditis.
- Acute preoperative neurological event (such as a stroke).
- Renal dialysis.
- History of substance abuse within one year, or a prison inmate.
- Participating in another study.
- Life expectancy less than two years.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Characterize the hemodynamic performance of the valve. At required follow-up intervals Characterize patient NYHA functional classification status. At required follow-up intervals Establish adverse event rates. Ongoing
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (5)
Montreal Heart Institute
🇨🇦Montreal, Quebec, Canada
Hôpital Laval
🇨🇦Québec, Quebec, Canada
University of British Columbia, St. Paul's Hospital
🇨🇦Vancouver, British Columbia, Canada
University Health Network - Toronto General Hospital
🇨🇦Toronto, Ontario, Canada
QEII Health Sciences Center
🇨🇦Halifax, Nova Scotia, Canada